“…Patients were categorized into groups with hepatitis B, hepatitis C, fatty liver disease, and patients without chronic hepatitis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The prevalence of alcoholic liver disease, hepatitis B, hepatitis C, and fatty liver disease was 10.6%, 10.9%, 3.7%, and 27.0%, respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Antiviral drug therapy is an excellent example, exemplified by the evolution of therapeutic approaches for treatment of hepatitis C and HIV-1. Nick Meanwell and his colleagues made important contributions leading to molecules for treatment of hepatitis C and HIV-1, each with distinct mechanisms of action. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In this review we present two cases: one patient whose first presentation of AIDS was end-stage renal disease, who on biopsy was found to have HIVAN, and the second, who was infected with HIV, and on biopsy was found to have hepatitis C-related hepatitis C related membranoproliferative glomerulonephritis. …”
Enlace del recurso
Enlace del recurso

“…Hepatitis C virus (HCV) affects about 170 million people worldwide and is the most common chronic blood borne infection in the United States. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The mechanisms of oncogenesis believed to operate in Hepatitis C lymphomagenesis are discussed, as is their potential applicability to Chikungunya Virus.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…It is known that miR-122, as an unusual host factor, increases the abundance of hepatitis C virus (HCV) RNA in HCV infection by binding directly to the 5’-UTR of the viral genome. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We report a case of membranoproliferative glomerulonephritis (MPGN) with IgMκ light chain deposits in a patient with chronic hepatitis C infection and simultaneous onset of monoclonal IgMκ gammopathy with concurrent small B-cell lymphoproliferative disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Necrolytic acral erythema (NAE) is a newly described entity, seen in patients infected with hepatitis C virus. It is characterized by its distinguishing acral distribution, psoriasiform skin eruption and histological features. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Therapy for human immunodeficiency virus (HIV) and chronic hepatitis C has evolved over the past decade, resulting in better control of infection and clinical outcomes; however, drug-drug interactions remain a significant hazard. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis C virus (HCV) has been shown to affect many tissues other than liver. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Cryoglobulinemic vasculitis (CV) is a systemic inflammatory syndrome involving small- to medium-sized vessels. Almost half of hepatitis C-infected patients have detectable cryoglobulins levels, but only very few develop clinical manifestations. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Chronic hepatitis C virus infection leads to the activation of innate immunity, a key component in HCV fibrosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Replication of hepatitis C virus (HCV) is tightly linked to membrane alterations designated the membranous web, harboring the viral replicase complex. …”
Enlace del recurso
Enlace del recurso

“…We present a patient with untreated hepatitis C virus and metastatic hepatocellular carcinoma treated with combination immunotherapy who developed elevated liver enzymes. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Furthermore, the impact of these newer medications on the risk of hepatitis C recurrence and progression remains to be elucidated. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Haematological abnormalities are common during combination antiviral therapy for chronic hepatitis C. Although dose reduction or discontinuation can easily treat these side effects, they can adversely affect the efficacy of combination antiviral therapy reducing the likelihood of a sustained viral response (SVR). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis C is a fatal liver disease caused by the hepatitis C virus. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Natural killer (NK) cells are capable of regulating viral infection without major histocompatibility complex restriction. Hepatitis C is caused by chronic infection with hepatitis C virus (HCV), and impaired activity of NK cells may contribute to the control of the disease progression, although the involvement of NK cells in vivo remains to be proven. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis C is an infectious disease, caused by blood borne pathogen; the Hepatitis C Virus. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso